Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-omics Characteristics and Prognosis in Patients With Idiopathic Sudden Sensorineural Hearing Loss

NCT06365775 is registered in ClinicalTrials.gov with Dan Bing as lead sponsor.

NCT NCT06365775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-omics Characteristics and Prognosis in Patients With Idiopathic Sudden Sensorineural Hearing Loss
Lead sponsor
Dan Bing
Phase
Observational
Overall status
Not yet recruiting
Start date
April 23, 2024
Completion date
November 23, 2026
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, sensorineural, hearing loss, sudden, sudden sensorineural hearing loss